Early warning signs include thirst, dry mouth, decreased urine output, darker urine, fatigue, dizziness, and headache
10.3389/fphar.2021.632295 Summary Keywords gastric pentadecapeptide BPC 157, primary abdominal compartment syndrome, rats, brain edema, lung edema Citation Tepes M, Gojkovic S, Krezic I, Zizek H, Vranes H, Madzar Z, Santak G, Batelja L, Milavic M, Sikiric S, Kocman I, Simonji K, Samara M, Knezevic M, Barisic I, Lovric E, Strbe S, Kokot A, Sjekavica I, Kolak T, Skrtic A, Seiwerth S, Boban Blagaic A and Sikiric P (2021) Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
10 , e0136508 (2015)
These medications combine the effects of a GLP-1 receptor agonist with an agonist for GIP, another hormone produced by the small intestine
For a more reliable and supportive experience, check out our guide to the top online GLP-1 clinics
Huang J, Wu T, Zhong Y, Huang J, Kang Z, Zhou B, et al